A detailed history of Cibc World Market Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cibc World Market Inc. holds 374,651 shares of BMY stock, worth $21.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
374,651
Previous 256,569 46.02%
Holding current value
$21.7 Million
Previous $10.7 Million 81.92%
% of portfolio
0.04%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $4.68 Million - $6.11 Million
118,082 Added 46.02%
374,651 $19.4 Million
Q2 2024

Aug 07, 2024

SELL
$40.25 - $52.99 $4.81 Million - $6.33 Million
-119,394 Reduced 31.76%
256,569 $10.7 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $9.83 Million - $11.1 Million
204,960 Added 119.86%
375,963 $20.4 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $2.22 Million - $2.65 Million
-45,766 Reduced 21.11%
171,003 $8.77 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $1.54 Million - $1.72 Million
-26,557 Reduced 10.91%
216,769 $12.6 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $6.45 Million - $7.16 Million
101,216 Added 71.22%
243,326 $15.6 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $779,911 - $884,596
-11,869 Reduced 7.71%
142,110 $9.85 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $79,231 - $93,821
-1,157 Reduced 0.75%
153,979 $11.1 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $3,895 - $2.3 Million
-29,962 Reduced 16.19%
155,136 $11 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $1.2 Million - $1.33 Million
16,580 Added 9.84%
185,098 $14.3 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $7.05 Million - $8.45 Million
-114,638 Reduced 40.49%
168,518 $12.3 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $774,846 - $903,288
14,448 Added 5.38%
283,156 $17.7 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $3.49 Million - $4.09 Million
-58,952 Reduced 17.99%
268,708 $15.9 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $836,342 - $910,776
13,509 Added 4.3%
327,660 $21.9 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $951,635 - $1.07 Million
-16,037 Reduced 4.86%
314,151 $19.8 Million
Q4 2020

Feb 08, 2021

SELL
$57.74 - $65.43 $654,136 - $741,256
-11,329 Reduced 3.32%
330,188 $20.5 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $1.73 Million - $1.92 Million
30,189 Added 9.7%
341,517 $20.6 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $711,070 - $831,311
-12,971 Reduced 4.0%
311,328 $18.3 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.62 Million - $2.36 Million
-34,989 Reduced 9.74%
324,299 $18.1 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $6.66 Million - $8.68 Million
135,297 Added 60.4%
359,288 $23.1 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $2.28 Million - $2.7 Million
53,205 Added 31.15%
223,991 $11.4 Million
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $3.92 Million - $4.34 Million
-87,921 Reduced 33.98%
170,786 $7.75 Million
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $1.22 Million - $1.46 Million
-27,074 Reduced 9.47%
258,707 $12.3 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $5.54 Million - $7.19 Million
-113,688 Reduced 28.46%
285,781 $14.9 Million
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $49.5 Million - $55.8 Million
-896,900 Reduced 69.19%
399,469 $24.8 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $51.4 Million - $64 Million
1,016,753 Added 363.62%
1,296,369 $71.7 Million
Q1 2018

May 18, 2018

SELL
$59.92 - $68.98 $2.21 Million - $2.55 Million
-36,917 Reduced 11.66%
279,616 $17.7 Million
Q4 2017

Feb 01, 2018

BUY
$59.94 - $65.35 $1.21 Million - $1.32 Million
20,192 Added 6.81%
316,533 $19.4 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $16.4 Million - $18.9 Million
296,341
296,341 $18.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.